Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
2019; Massachusetts Medical Society; Volume: 381; Issue: 20 Linguagem: Inglês
10.1056/nejmoa1902626
ISSN1533-4406
AutoresRobert L. Coleman, Nick M. Spirtos, Danielle Enserro, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Jae‐Weon Kim, Sang‐Yoon Park, Byoung‐Gie Kim, Joo-Hyun Nam, Keiichi Fujiwara, Joan L. Walker, A.Catherine Casey, Angeles Alvarez Secord, Steve Rubin, John K. Chan, Paul DiSilvestro, Susan A. Davidson, David E. Cohn, Krishnansu S. Tewari, Karen Basen‐Engquist, Helen Q. Huang, Mark F. Brady, Robert S. Mannel,
Tópico(s)Ovarian function and disorders
ResumoSecondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation.
Referência(s)